Swiss National Bank’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.85M Buy
168,800
+7,000
+4% +$201K ﹤0.01% 1317
2025
Q1
$5.43M Buy
161,800
+2,400
+2% +$80.5K ﹤0.01% 1213
2024
Q4
$8.15M Buy
159,400
+28,500
+22% +$1.46M 0.01% 1044
2024
Q3
$6.69M Buy
130,900
+600
+0.5% +$30.7K ﹤0.01% 1148
2024
Q2
$5.84M Buy
130,300
+3,800
+3% +$170K ﹤0.01% 1178
2024
Q1
$5.92M Buy
126,500
+22,300
+21% +$1.04M ﹤0.01% 1186
2023
Q4
$3.71M Sell
104,200
-12,200
-10% -$434K ﹤0.01% 1470
2023
Q3
$3.46M Buy
116,400
+34,200
+42% +$1.02M ﹤0.01% 1506
2023
Q2
$1.48M Buy
82,200
+900
+1% +$16.2K ﹤0.01% 2081
2023
Q1
$1.31M Sell
81,300
-9,500
-10% -$153K ﹤0.01% 2088
2022
Q4
$1.66M Buy
90,800
+2,800
+3% +$51.2K ﹤0.01% 2016
2022
Q3
$1.73M Hold
88,000
﹤0.01% 1971
2022
Q2
$1.64M Buy
88,000
+9,300
+12% +$173K ﹤0.01% 2056
2022
Q1
$1.73M Buy
78,700
+7,700
+11% +$169K ﹤0.01% 2120
2021
Q4
$2.02M Buy
71,000
+21,400
+43% +$608K ﹤0.01% 2055
2021
Q3
$1.04M Hold
49,600
﹤0.01% 2420
2021
Q2
$935K Buy
49,600
+12,000
+32% +$226K ﹤0.01% 2505
2021
Q1
$575K Buy
37,600
+1,400
+4% +$21.4K ﹤0.01% 2446
2020
Q4
$511K Hold
36,200
﹤0.01% 2458
2020
Q3
$567K Hold
36,200
﹤0.01% 2334
2020
Q2
$634K Buy
36,200
+17,400
+93% +$305K ﹤0.01% 2316
2020
Q1
$276K Buy
18,800
+900
+5% +$13.2K ﹤0.01% 2360
2019
Q4
$449K Hold
17,900
﹤0.01% 2443
2019
Q3
$269K Hold
17,900
﹤0.01% 2469
2019
Q2
$448K Buy
+17,900
New +$448K ﹤0.01% 2446